Patents by Inventor Todd Mendelson
Todd Mendelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11376141Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: GrantFiled: June 26, 2020Date of Patent: July 5, 2022Assignee: COVIDIEN LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Publication number: 20200323664Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: ApplicationFiled: June 26, 2020Publication date: October 15, 2020Inventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Patent number: 10695200Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: GrantFiled: February 15, 2019Date of Patent: June 30, 2020Assignee: COVIDIEN LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Publication number: 20190175373Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: ApplicationFiled: February 15, 2019Publication date: June 13, 2019Inventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Patent number: 10226366Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: GrantFiled: January 12, 2017Date of Patent: March 12, 2019Assignee: Covidien LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Publication number: 20170119557Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.Type: ApplicationFiled: January 12, 2017Publication date: May 4, 2017Inventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-shyan Sheu
-
Patent number: 9545301Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.Type: GrantFiled: June 27, 2014Date of Patent: January 17, 2017Assignee: Covidien LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Patent number: 9320592Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.Type: GrantFiled: March 15, 2013Date of Patent: April 26, 2016Assignee: Covidien LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Masoud Molaei, Victoria Schuman, Min-Shyan Sheu
-
Publication number: 20150081003Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.Type: ApplicationFiled: June 27, 2014Publication date: March 19, 2015Applicant: Covidien LPInventors: John WAINWRIGHT, Todd MENDELSON, Kurt HAGGSTROM, Masoud MOLAEI, Victoria SCHUMAN, Min-Shyan SHEU
-
Publication number: 20140277400Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Applicant: COVIDIEN LPInventors: John Wainwright, Todd Mendelson, Kurt Haggstrom, Xiaodong Ma, Masoud Molaei, John Muri, Anastasia Righter, Victoria Schuman, Min-Shyan Sheu
-
Patent number: 6214015Abstract: An IOL compression chamber for folding an IOL includes a hollow chamber having a loading area, a staging area and a distal tip. The loading area has a distally extending slot in the wall which allows for easy removal of a forceps holding the IOL from the chamber following insertion of the IOL into the chamber with the forceps. The staging area holds the IOL in a folded state until the chamber is placed into an IOL insertion instrument having a plunger which forces the IOL distally out of the staging area and into the eye through the distal tip.Type: GrantFiled: September 17, 1998Date of Patent: April 10, 2001Assignee: Bausch & Lomb Surgical, Inc.Inventors: Cary J. Reich, Todd A. Mendelson, Bradley S. Stone, Michael W. Orchowski
-
Patent number: 5860986Abstract: An IOL compression chamber for folding an IOL includes a hollow chamber having a loading area, a staging area and a distal tip. The loading area has a distally extending slot in the wall, which allows for easy removal of a forceps holding the IOL from the chamber following insertion of the IOL into the chamber with the forceps. The staging area holds the IOL in a folded state until the chamber is placed into an IOL insertion instrument having a plunger which forces the IOL distally out of the staging area and into the eye through the distal tip.Type: GrantFiled: May 6, 1997Date of Patent: January 19, 1999Assignee: Chiron Vision CorporationInventors: Cary J. Reich, Todd A. Mendelson, Bradley S. Stone, Michael W. Orchowski
-
Patent number: 5653715Abstract: An IOL compression chamber for folding an IOL includes a hollow chamber having a loading area, a staging area and a distal tip. The loading area has a distally extending slot in the wall which allows for easy removal of a forceps holding the IOL from the chamber following insertion of the IOL into the chamber with the forceps. The staging area holds the IOL in a folded state until the chamber is placed into an IOL insertion instrument having a plunger which forces the IOL distally out of the staging area and into the eye through the distal tip.Type: GrantFiled: March 9, 1993Date of Patent: August 5, 1997Assignee: Chiron Vision CorporationInventors: Cary J. Reich, Todd A. Mendelson, Bradley S. Stone, Michael W. Orchowski
-
Patent number: 5474562Abstract: An apparatus in which a deformable or compressible intraocular lens can be received and staged for insertion into a patient's eye. The apparatus has an elongated compression chamber with proximal and distal ends and a longitudinal passageway, having an inner surface, extending between the ends. The portion of the passageway adjacent to the proximal end forms a loading area in which the passageway gradually decreases in size for causing an intraocular lens to be deformed or compressed as the lens is moved along the passageway. A staging area having a top and bottom passageway wall, communicates with the loading area with the passageway wall including alignment means for retaining the intraocular lens in a deformed or compressed condition. A portion of the passageway is sized to retain the intraocular lens in the deformed or compressed condition.Type: GrantFiled: March 9, 1994Date of Patent: December 12, 1995Assignee: Chiron Vision CorporationInventors: Michael W. Orchowski, Bradley S. Stone, Cary J. Reich, Todd A. Mendelson, Robert J. Sullivan, Alok Nigam